Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.46 USD
Change Today -0.66 / -1.93%
Volume 26.9M
As of 8:04 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Barbara J. Dalton Ph.D.

Head of In-house Venture Capital Arm, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 125 board members in 4 different organizations across 8 different industries.

See Board Relationships
61--

Background*

Dr. Barbara J. Dalton, Ph.D. serves as a Venture Investment Lead of Pfizer Venture Investments. Dr. Dalton served as the Vice President of Venture Capital at Pfizer Venture Investments. Dr. Dalton has been Head of In-house Venture Capital Arm at Pfizer Inc. since July 16, 2007. She served as President of SR One. Dr. Dalton served as the President at Mid-Atlantic Capital Alliance and EuclidSR Partners, L.P. She was a General Partner of EuclidSR Partners. Dr. Dalton spent ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Former President and Director
Prior
Director
Former Director
Director
Former Chairman
Former Director
Former Member of the Board of Directors
Director
Director
Member of Board of Managers
Director
2012-2014
Former Director

Education*

Unknown/Other Education
Pennsylvania State University
PhD
Drexel University College of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $33.46 USD -0.66

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
SFr.5.7M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.3M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.